GIPERXOLISTERINEMIYA KASALLIGINI DAVOLASHDA STATINLARDAN HAMDA TABIIY O`SIMLIKLARDAN FOYDALANISH
Ключевые слова:
Kalit so‘zlar: Giperxolesterinemiya, statinlar, BFQ, ALT, AST, bilirubin, atorvastatin, rozuvastatin, pitavastatin, ateroskleroz, “Silimarin plus”.Аннотация
Ushbu maqolada giperxolesterinemiya kasalligini davolash usullari, xususan, statinlarni uzoq muddat qabul qilishda yuzaga keladigan nojo‘ya ta’sirlar va ularni nazorat qilish usullari tahlil qilinadi. Shuningdek, tabiiy o‘simlik tarkibli biologik faol qo‘shimchalar (BFQ) – xususan, “Silimarin plus” kompleksi misolida alternativ terapiya yondashuvlari ko‘rib chiqiladi.
Библиографические ссылки
FOYDALANILGAN ADABIYOTLAR
1. Abdulkhalev LA, et al. Flavonoids and their anti-diabetic effects: Cellular mechanisms and therapeutic potential. Phytochemistry Reviews. 2018;17(5):1095–1111.
2. Buettner C, et al. Statin use and risk of cognitive decline in the elderly. Neurology. 2008;71(5):344–349.
3. Demir D, et al. Effects of vitamin D supplementation on statin-associated muscle symptoms. Archives of Medical Science. 2019;15(2):385–393.
4. Flora K, et al. Milk thistle (Silybum marianum) for the therapy of liver disease. The American Journal of Gastroenterology. 1998;93(2):139–143.
5. Gylling H, et al. Plant stanols and sterols in the management of dyslipidemia and prevention of cardiovascular disease. Atherosclerosis. 2014;232(2):346–360.
6. Houghton PJ, et al. Mint species: In vitro studies of antimicrobial and antioxidant activity. Phytotherapy Research. 2002;16(5):467–471.
7. Kamisako T, et al. Protective effects of flavonoids against cardiovascular diseases: A review. Journal of Nutritional Science and Vitaminology. 2017;63(Supplement):S55–S59.
8. Kim DS, et al. Antioxidant and anti-inflammatory effects of Coriandrum sativum L. seed extract in vitro. Journal of Food Biochemistry. 2015;39(5):561–568.
9. Kohlmeier M, et al. Nutrient metabolism: Structures, functions, and genes. Academic Press. 2015. Chapter: Vitamin D and Muscle Function.
10. Lerman RH, et al. Clinical applications of botanical medicine in dyslipidemia. Alternative Therapies in Health and Medicine. 2010;16(2):44–52.
11. Li H, et al. Natural products in the treatment of hyperlipidemia: A review based on their mechanisms of action. Biomedicine & Pharmacotherapy. 2020;127:110142.
12. Mangge H, et al. The role of vitamin D in statin-associated muscle symptoms. Current Opinion in Lipidology. 2015;26(6):319–325.
13. Ostlund RE Jr., Phytosterols and cholesterol metabolism. Current Opinion in Lipidology. 2004;15(1):37–41.
14. Park H, et al. Protective effects of Styphnolobium japonicum extract on vascular inflammation and endothelial dysfunction. Pharmaceutical Biology. 2017;55(1):1426–1433.
15. Pilz S, et al. Vitamin D and cardiovascular disease prevention. Nature Reviews Cardiology. 2016;13:404–417.
16. Ruscica M, et al. Statin-associated myopathy: A meta-analysis of randomized clinical trials. European Journal of Internal Medicine. 2020;73:40–49.
17. Shapiro MD, et al. A practical guide to statin safety and side effects. J Am Coll Cardiol. 2016;67(20):2395–2410.
18. Stone NJ, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology. 2019;73(24):e285–e350.
19. Toth PP, et al. Clinical characteristics and treatment patterns of patients with statin-associated muscle symptoms. Journal of Clinical Lipidology. 2014;8(6):611–618.
20. Zhang YJ, et al. Styphnolobium japonicum: A source of flavonoids with potential health benefits. Pharmaceutical Biology. 2014;52(8):1008–1013.
